HIST1H4A (Ab-79) Antibody is a polyclonal antibody raised in rabbits against a specific peptide sequence surrounding the lysine 79 site of human Histone H4. Histone H4 is a core component of nucleosomes, which are fundamental units of chromatin structure that wrap and compact DNA. The antibody specifically recognizes the region around position 79, which can undergo post-translational modifications such as acetylation that play crucial roles in epigenetic regulation .
The target of this antibody, Histone H4, is encoded by several genes including HIST1H4A, HIST1H4B, HIST1H4C, and others, reflecting the high conservation and importance of histones in cellular function. The antibody's specificity for the lysine 79 position makes it particularly valuable for studying specific epigenetic marks at this location .
HIST1H4A (Ab-79) Antibody has been validated for multiple research applications, making it a versatile tool in epigenetics and chromatin research. The antibody performs effectively across various techniques commonly used in molecular biology and cell biology research.
The antibody has been validated for Western blotting with a recommended dilution range of 1:500-1:5000. It has successfully detected Histone H4 in various cell lysates including 293, NIH/3T3, K562, and A549 cell lines, as well as mouse kidney tissue . This application allows researchers to quantify Histone H4 protein levels and study its post-translational modifications in various experimental conditions.
For immunohistochemistry applications, particularly in paraffin-embedded tissues (IHC-P), the recommended dilution range is 1:1-1:10 . The antibody has been successfully used to detect Histone H4 in human liver cancer tissue, demonstrating its utility in studying histone modifications in pathological conditions .
The antibody has been validated for ELISA applications, providing researchers with a tool for quantitative measurement of Histone H4 and its modifications in complex biological samples . This application is particularly useful for high-throughput screening and quantitative analysis of histone modifications.
Select variants of the HIST1H4A (Ab-79) Antibody have been validated for Chromatin Immunoprecipitation (ChIP) assays . This application is crucial for studying histone-DNA interactions and mapping histone modifications across the genome, providing insights into epigenetic regulation of gene expression.
The antibody has also been validated for immunofluorescence (IF) and immunocytochemistry (ICC) applications with recommended dilutions of 1:1-1:10 for IF and 1:10-1:100 for ICC . These techniques allow visualization of Histone H4 and its modifications within cellular contexts, providing spatial information about histone distribution and modification patterns.
The antibody is typically supplied in a specialized buffer designed to maintain stability and activity:
This formulation helps maintain antibody stability and prevents microbial contamination during storage.
HIST1H4A (Ab-79) Antibody has proven particularly valuable in epigenetics and nuclear signaling research. Histone H4 is a core component of nucleosomes that wrap and compact DNA, and modifications at the lysine 79 position are associated with specific regulatory functions in gene expression .
The antibody has been used to investigate:
Histone modifications in cancer tissues, as evidenced by its application in human liver cancer tissue studies
Epigenetic regulation in various cell lines including 293, NIH/3T3, K562, and A549
Chromatin structure and function through ChIP experiments that map histone modifications across the genome
Post-translational modifications, particularly acetylation at lysine 79, which is associated with active gene transcription
Research using this antibody contributes to the broader understanding of epigenetic mechanisms that regulate gene expression, development, and disease progression.
HIST1H4A belongs to the histone H4 family, which are basic nuclear proteins responsible for the nucleosome structure of chromosomal fiber in eukaryotes. Histones are fundamental components of chromatin, where two molecules of each core histone (H2A, H2B, H3, and H4) form an octamer around which approximately 146 bp of DNA wraps to create nucleosomes. HIST1H4A is intronless and is located within the large histone gene cluster on chromosome 6 . Unlike typical mRNA, transcripts from this gene lack polyA tails and instead contain a palindromic termination element . The protein plays a critical role in DNA packaging and chromosome condensation during cell division and influences gene expression through various post-translational modifications.
The HIST1H4A (Ab-79) Polyclonal Antibody has been validated for multiple research applications that allow for diverse experimental approaches:
When designing experiments, researchers should note that this antibody is specifically developed for human samples and cross-reactivity with other species should be verified before use in comparative studies .
The HIST1H4A (Ab-79) antibody is designed to recognize and bind to a peptide sequence around the site of Lysine 79 (Lys79) derived from Human Histone H4 . This specificity is important for researchers studying histone modifications in this region. The antibody has been developed using rabbits as the host organism and is of IgG isotype . The polyclonal nature of this antibody means it can recognize multiple epitopes of the target antigen, potentially increasing sensitivity but requiring careful validation of specificity.
For researchers interested in post-translational modifications, it's worth noting that other specialized antibodies such as those detecting formylation at K91 are also available for histone H4 research , suggesting that researchers should carefully select the appropriate antibody based on the specific modification site they are investigating.
For optimal results with the HIST1H4A (Ab-79) antibody, sample preparation protocols should be tailored to the specific application:
For Western Blotting:
Prepare cell lysates in a buffer containing protease inhibitors to prevent histone degradation
For histone-specific preparation, consider acid extraction methods that enrich for basic proteins
Load 15-25 μg of total protein per lane (based on NIH/3T3 cell lysate loading)
Use SDS-PAGE with appropriate percentage gels for low molecular weight proteins (the predicted band size for histone H4 is approximately 11 kDa)
For ELISA Applications:
Sample dilution should be carefully considered based on expected protein concentration
Linearity of dilution studies indicate that serum samples show good recovery (95-108% at 1:1 dilution)
Detection range for commercial ELISA kits is typically 37.5-2400 pg/mL with a sensitivity of 9.3 pg/mL
For Chromatin Immunoprecipitation:
Crosslink proteins to DNA using formaldehyde (typically 1% for 10 minutes)
Sonicate chromatin to appropriate fragment sizes (200-500 bp)
Use 2-5 μg of antibody per immunoprecipitation reaction
Include appropriate controls (input, IgG control, positive control target)
When designing experiments using the HIST1H4A (Ab-79) antibody, incorporating appropriate controls is essential for result interpretation and troubleshooting:
Positive Controls:
Known histone H4-expressing cell lines (most eukaryotic cells express histones)
Recombinant histone H4 protein
Previously validated sample with confirmed histone H4 expression
Negative Controls:
Secondary antibody only (no primary antibody) to assess background
Isotype control (rabbit IgG) to identify non-specific binding
Peptide competition assay using the immunizing peptide to confirm specificity
Application-Specific Controls:
For ChIP: Input chromatin (pre-immunoprecipitation sample)
For ELISA: Standard curve using recombinant HIST1H4A protein
For IHC/IF: Tissue known to be negative for the target or with primary antibody omitted
Validation Controls:
HIST1H4A has been shown to interact with multiple proteins that may impact chromatin structure and function. Researchers should consider these interactions when designing experiments and interpreting results:
These interactions suggest that HIST1H4A may be involved in diverse cellular processes beyond its structural role in chromatin. The strong interaction with RAB5C (standardized value: 0.682774) indicates potential involvement in membrane trafficking pathways, while interaction with ATP5B suggests possible links to cellular energetics .
When designing co-immunoprecipitation experiments or studying chromatin complexes, researchers should consider these interaction partners as potential confounding factors or additional targets for investigation.
Chromatin Immunoprecipitation (ChIP) using HIST1H4A (Ab-79) antibody requires specific methodological considerations to optimize results:
Chromatin Preparation:
Crosslinking: Use 1% formaldehyde for 10 minutes at room temperature for most cell types
Sonication: Optimize sonication conditions to achieve DNA fragments of 200-500 bp
Chromatin quality: Verify fragmentation by agarose gel electrophoresis before proceeding
Immunoprecipitation Protocol:
Pre-clearing: Use protein A/G beads to reduce non-specific binding
Antibody amount: Use 2-5 μg of HIST1H4A (Ab-79) antibody per reaction
Incubation time: Overnight incubation at 4°C generally yields optimal results
Washing stringency: Use increasingly stringent wash buffers to reduce background
Data Analysis Considerations:
Normalization: Compare enrichment to input chromatin and IgG control
Positive control loci: Include primers for known histone H4-enriched genomic regions
Sequencing considerations: For ChIP-seq, ensure sufficient sequencing depth (>20 million reads)
Histone H4 undergoes numerous post-translational modifications (PTMs) that regulate chromatin structure and function. To effectively study these modifications:
Selection of Modification-Specific Antibodies:
For lysine 79 modifications: Use the HIST1H4A (Ab-79) antibody as it targets this region
For other modifications: Select antibodies specific to the modification of interest (e.g., formylation at K91)
Validate antibody specificity against peptide arrays containing modified and unmodified peptides
Experimental Approaches:
Western blotting: Use modification-specific antibodies alongside total H4 antibodies
Mass spectrometry: For unbiased identification of multiple PTMs simultaneously
ChIP-seq: Map genome-wide distribution of specific histone modifications
Sequential ChIP (Re-ChIP): Identify genomic regions containing multiple modifications
Quantification Methods:
ELISA assays: Provide quantitative measurement of specific modifications with sensitivity down to 9.3 pg/mL
Protein arrays: Allow multiplexed detection of multiple histone modifications
Imaging approaches: Visualize spatial distribution of modifications within nuclei
When studying histone modifications, it's crucial to consider the dynamic nature of these marks and their potential crosstalk. For example, modifications at one residue may influence the accessibility or recognition of nearby sites by modifying enzymes or antibodies.
When working with HIST1H4A (Ab-79) antibody across different experimental systems, researchers should be aware of several potential challenges:
Cross-Reactivity Considerations:
Species specificity: The antibody is validated for human samples but may show variable cross-reactivity with other species
Histone variant recognition: Given the high sequence conservation among H4 variants, verify specificity against closely related proteins
Epitope masking: Post-translational modifications near Lys79 may affect antibody binding
Technical Challenges by Application:
Western Blotting:
Low molecular weight of histones (11 kDa) requires appropriate gel percentage
Histones are highly basic proteins that may need specialized transfer conditions
Immunohistochemistry:
Fixation methods significantly impact histone epitope accessibility
Nuclear localization requires careful permeabilization optimization
ELISA:
Reproducibility Considerations:
Lot-to-lot variation: Polyclonal antibodies may show batch variation
Sample preparation consistency: Histone extraction methods should be standardized
Quantification challenges: ELISA kits show intra-assay precision (CV<8%) and inter-assay precision (CV<10%)
Integrating HIST1H4A research into broader epigenetic studies requires consideration of multiple molecular mechanisms and analytical approaches:
Multi-Omics Integration Strategies:
Combine ChIP-seq data using HIST1H4A (Ab-79) antibody with:
RNA-seq to correlate histone modifications with gene expression
ATAC-seq to assess chromatin accessibility
DNA methylation profiling to understand epigenetic crosstalk
Functional Analysis Approaches:
CRISPR-based histone modification: Target specific modifications at HIST1H4A
Histone demethylase/methyltransferase inhibitors: Assess impact on HIST1H4A modifications
Single-cell approaches: Investigate cell-to-cell variability in HIST1H4A modifications
Biological Context Considerations:
Cell cycle analysis: HIST1H4A modifications change during different cell cycle phases
Development and differentiation: Study dynamic changes during cellular differentiation
Disease models: Compare HIST1H4A modifications in normal vs. pathological states
Data Analysis Frameworks:
Enrichment analysis: Identify biological pathways associated with HIST1H4A-bound regions
Motif analysis: Determine transcription factors that co-localize with HIST1H4A modifications
Chromosome conformation data integration: Connect HIST1H4A modifications with 3D genome organization
When examining protein interactions, researchers should note that HIST1H4A interacts with diverse proteins including chromatin components (HIST1H2BL), metabolic enzymes (ATP5B, ATP5A1), and signaling molecules (RAB5C) , suggesting involvement in multiple cellular processes beyond chromatin structure.
When experiments with HIST1H4A (Ab-79) antibody don't yield expected results, consider these troubleshooting approaches:
For Weak or No Signal:
Antibody concentration: Titrate antibody to determine optimal concentration
Epitope accessibility: Modify fixation/permeabilization protocols to improve antigen retrieval
Sample preparation: Ensure histones are properly extracted and not degraded
Detection system: Verify secondary antibody functionality and consider signal amplification
For High Background:
Blocking optimization: Test different blocking reagents (BSA, milk, serum)
Washing stringency: Increase number and duration of wash steps
Antibody specificity: Perform peptide competition assay to verify specific binding
Sample quality: Reduce endogenous peroxidase activity or autofluorescence
For Unexpected Results:
Positive controls: Include known HIST1H4A-expressing samples
Band size verification: Confirm correct molecular weight (11 kDa for histone H4)
Lot testing: Compare results across different antibody lots
Protocol consistency: Standardize all steps of the experimental workflow
Comprehensive validation of HIST1H4A (Ab-79) antibody ensures reliable experimental outcomes:
Specificity Validation:
Peptide array testing: Verify binding to target peptide versus related sequences
Western blot: Confirm single band at expected molecular weight (11 kDa)
Knockdown/knockout controls: Reduced signal in HIST1H4A-depleted samples
Peptide competition: Pre-incubation with immunizing peptide should abolish signal
Performance Validation:
Sensitivity assessment: Determine lower limit of detection (ELISA sensitivity: 9.3 pg/mL)
Dynamic range: Verify linear detection range (ELISA range: 37.5-2400 pg/mL)
Reproducibility testing:
Application-Specific Validation:
For IHC/IF: Staining pattern should match known nuclear localization
For ChIP: Enrichment at known histone H4-associated genomic regions
For ELISA: Recovery testing across sample types (serum recovery: 93%, range 89-97%)
Research utilizing tools like the HIST1H4A (Ab-79) antibody is advancing our understanding of chromatin dynamics in several key areas:
Nucleosome Assembly and Stability:
HIST1H4A interactions with other histones, particularly HIST1H2BL (interaction value: 0.269638) , provide insights into nucleosome assembly mechanisms
Studies of HIST1H4A modifications help explain how chromatin structure changes during cell cycle progression
Regulatory Networks:
Interactions between HIST1H4A and non-histone proteins such as RAB5C (interaction value: 0.682774) suggest unexpected connections between chromatin and membrane trafficking pathways
HIST1H4A association with metabolic enzymes like ATP5B (interaction value: 0.578784) points to potential links between cellular energetics and chromatin structure
Technological Advances:
Antibodies targeting specific HIST1H4A modifications enable genome-wide mapping of epigenetic landscapes
Increasing specificity of tools like the HIST1H4A (Ab-79) antibody allows for more precise dissection of histone variant functions
Several cutting-edge research areas could be advanced through applications of HIST1H4A (Ab-79) antibody:
Single-Cell Epigenomics:
Adaptation of ChIP protocols for single-cell analysis to study cell-to-cell variation in HIST1H4A modifications
Integration with single-cell transcriptomics to correlate histone modifications with gene expression heterogeneity
Liquid Biopsy Development:
Detection of circulating HIST1H4A in serum samples as potential biomarkers (ELISA sensitivity: 9.3 pg/mL)
Monitoring dynamic changes in histone modifications during disease progression
Therapeutic Target Validation:
Studying how experimental drugs affect HIST1H4A modifications and interactions
Identifying specific HIST1H4A modifications associated with disease states
Developmental Biology:
Mapping changes in HIST1H4A modifications during cellular differentiation
Understanding the role of specific histone variants in developmental programming